Activin RIB

Activin RIB Overview

English NameTransforming growth factor beta receptor 1Approved Drugs0
Drugs in Clinical Trials7Target SynonymEC 2.7.11,TGF-beta type I receptor,Serine/threonine-protein kinase receptor R4,TGFBR1,Activin A receptor type II-like protein kinase of 53kD,Transforming Growth Factor Beta Receptor 1,Transforming Growth Factor-Beta Receptor Type I,Activin A Receptor Type II-Like Kinase, 53kDa,Activin Receptor-Like Kinase 5,TGFR-1,ALK-5,ALK5,SKR4,Mutant Transforming Growth Factor Beta Receptor I,TGF-Beta Receptor Type-1,TGF-Beta Receptor Type I,EC 2.7.11.30,ACVRLK4,LDS1A,LDS2A,AAT5,LDS1,TBRI,ESS1,MSSE,TbetaR-I,Transforming Growth Factor Beta Receptor I,Multiple Self-Healing Squamous Epithelioma,TBR-I,Receptor, Transforming Growth Factor-beta Type I,EC:2.7.11.30
Highest Development StagePhase 3 Clinical
English NameTransforming growth factor beta receptor 1
Target SynonymEC 2.7.11,TGF-beta type I receptor,Serine/threonine-protein kinase receptor R4,TGFBR1,Activin A receptor type II-like protein kinase of 53kD,Transforming Growth Factor Beta Receptor 1,Transforming Growth Factor-Beta Receptor Type I,Activin A Receptor Type II-Like Kinase, 53kDa,Activin Receptor-Like Kinase 5,TGFR-1,ALK-5,ALK5,SKR4,Mutant Transforming Growth Factor Beta Receptor I,TGF-Beta Receptor Type-1,TGF-Beta Receptor Type I,EC 2.7.11.30,ACVRLK4,LDS1A,LDS2A,AAT5,LDS1,TBRI,ESS1,MSSE,TbetaR-I,Transforming Growth Factor Beta Receptor I,Multiple Self-Healing Squamous Epithelioma,TBR-I,Receptor, Transforming Growth Factor-beta Type I,EC:2.7.11.30
Approved Drugs0
Drugs in Clinical Trials7
Highest Development StagePhase 3 Clinical

Activin RIB Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
ACB-H52H4
Human
HEK293
Human Activin RIB / ACVR1B Protein, His Tag
Total: 1
  • 1

Activin RIB Background

Activin receptor type-1B (ACVR1B) is also known as Activin receptor-like kinase 4 (ALK-4), Serine/threonine-protein kinase receptor R2 (SKR2), which belongs to the protein kinase superfamily, TKL Ser/Thr protein kinase family and TGFB receptor subfamily. ACVR1B contains one GS domain and one protein kinase domain. The catalytic activity of ACVR1B is “ATP + [receptor-protein] = ADP + [receptor-protein] phosphate”. ACVR1B acts as a transducer of activin or activin like ligands (e.g., inhibin) signals. Activin binds to either ACVR2A or ACVR2B and then forms a complex with ACVR1B. These go on to recruit the R-SMADs SMAD2 or SMAD3. ACVR1B also transduces signals of nodal, GDF-1, and Vg1.

Activin RIB Synonyms

ACVR1b,ALK4,ACVRLK4,ACTR-IB,SKR2

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
GalunisertibLY-2157299Phase 3 ClinicalEli Lilly And CompanyAmyotrophic Lateral Sclerosis; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Glioblastoma; Glioma; Liver Neoplasms; Metastatic breast cancer; Myelodysplastic Syndromes; Nasopharyngeal Carcinoma; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
Details
GF-101GFH-018; GF-101; GFH018Phase 2 ClinicalGenfleet Therapeutics (Shanghai) Co LtdCarcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Liver Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
Tosposertib phosphateTU-2218; NCE401; NCE-401Phase 2 ClinicalTiumBio Co LtdIdiopathic Pulmonary Fibrosis; Solid tumours
Details
OntunisertibORG-129; AGMB-129Phase 2 ClinicalOrigo Biopharma Sociedad LitmitadaCrohn Disease
Details
TRK-250TRK-250; BNC-1021Phase 1 ClinicalBonac CorpIdiopathic Pulmonary Fibrosis
Details
OxinsetiSH-3051Phase 1 ClinicalNanjing Sanhome Pharmaceutical Co Ltd Liver Neoplasms; Solid tumours
Details
AGMB-447AGMB-447; ORG-447Phase 1 ClinicalAgomAb Therapeutics NVIdiopathic Pulmonary Fibrosis
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호